---
title: 全球加强抗击超级细菌“威胁”
date: 2024-05-16T04:00:58.578Z
description: GSK joins UK government in committing £130mn to tackle growth of antimicrobial resistance
tag: 

- Tag world
author: ft
---

[原文链接](https://ft.com/content/6249ee67-8c63-46fe-8afa-8493c8788340)

# 全球加强抗击超级细菌“威胁”

**全球卫生界**正在加大努力，以应对日益严重的**抗微生物药物耐药性**（AMR）威胁，并得到了**英国政府**和**制药巨头 GSK** 的大力资金承诺。 目前已承诺提供共计1.3亿英镑用于应对这一关键问题，突显了加强防御以抗击**抗药性超级细菌**的紧迫性和重要性。

在 9 月举行的联合国抗微生物药物耐药性会议之前，这一资金支持将为在伦敦举行的部长和卫生专家会议所宣布，会议由英国 AMR 问题特使戴姆·莎莉·戴维斯主持。该活动的目标是倡导加强全球行动和增加资金，以应对 AMR 带来的“生存威胁”，特别是在**中低收入国家**。

资金分配策略重点是改善现有药物的获取渠道并确保其有效使用，而不是开发新抗生素。这种方法对于减缓耐药性微生物的进化和降低 AMR 对全球健康和经济的影响至关重要。

GSK 的承诺包括与新成立的 **弗莱明倡议** 合作，这是一个以亚历山大·弗莱明发现青霉素的地点为基地的全球网络。该倡议将利用**人工智能**来加强对耐药细菌的监控并改善诊断，确保患者得到正确的抗生素治疗。

此外，正在筹建一个全球 AMR 独立专家小组，其模式类似于政府间气候变化专门委员会，强调科学界承认 AMR 是一个紧迫的全球性挑战，其重要性与气候变化相当。

虽然初步研究表明，之前对 AMR 影响的估计可能被夸大了，但专家警告说，抗击超级细菌的斗争绝不能松懈。在拯救生命和经济收益方面，投资回报潜力远远超过不作为的成本。

---

# Global fight intensifies against superbug 'menace' 

**The global health community** is ramping up efforts to combat the growing threat of **antimicrobial resistance** (AMR), with significant financial commitments from both the **UK government** and **pharmaceutical giant GSK**. A total of £130 million has been pledged to tackle this critical issue, highlighting the urgency and importance of strengthening our defenses against **drug-resistant superbugs**. 

/n/n

This funding boost comes ahead of a UN conference on AMR in September and will be announced at a meeting in London, bringing together ministers and health experts. The event, hosted by Dame Sally Davies, the UK special envoy on AMR, aims to advocate for stronger global action and increased funding to address the "existential threat" posed by AMR, particularly in **low- and middle-income countries**. 

/n/n

The funding allocation, £85 million from the UK government and £45 million from GSK, is strategically focused on improving access to existing drugs and ensuring their effective use, rather than developing new antibiotics. This approach is crucial to slow down the evolution of drug-resistant microbes and reduce the impact of AMR on global health and economies. 

/n/n

GSK's commitment includes their partnership with the newly established **Fleming Initiative**, a global network based at the site of Alexander Fleming's discovery of penicillin. This initiative will leverage **artificial intelligence** to enhance surveillance of drug-resistant bacteria and improve diagnosis, ensuring patients receive the right antibiotics. 

/n/n

Additionally, a global independent panel for AMR, modeled after the Intergovernmental Panel on Climate Change, is in the works, emphasizing the scientific community's recognition of AMR as a pressing global challenge on par with climate change. 

/n/n

While preliminary studies suggest that previous estimates of AMR's impact may have been overstated, experts caution that the fight against superbugs must be unwavering. The potential return on investment in terms of saved lives and economic gains far outweighs the costs of inaction.

[Source Link](https://ft.com/content/6249ee67-8c63-46fe-8afa-8493c8788340)

